54
Views
8
CrossRef citations to date
0
Altmetric
Review

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

, , , &
Pages 3363-3372 | Published online: 10 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (8)